Patients are set to benefit from the use of innovative technology such as artificial intelligence in medical imaging and pathology, through five new centres announced today by the government.
These centres of excellence, with partnerships across the NHS, universities and industry, will work collaboratively across the UK to develop technology solutions and products for more intelligent analysis of medical imaging and pathology data. The aim is to diagnose diseases at an earlier stage, create better clinical decisions for patients, and free up more staff time for direct patient care across the NHS.
The investment in these centres – based in Leeds, Oxford, Coventry, Glasgow and London – will help drive a new understanding of how complex diseases develop, in a proactive step to ensure people get the right treatment at the right time.
The centres will be funded through the Industrial Strategy Challenge Fund, the government’s flagship investment programme that focusses on addressing the opportunities and challenges of the future. This Fund is managed by UK Research and Innovation (UKRI), and includes investment in the Digital Innovation Hub Programme, led by Health Data Research UK.
Professor Andrew Morris, Director of Health Data Research UK, said:
“These centres of excellence have a major opportunity to transform health outcomes for patients and the public using new technology and data in a responsible and ethical way. The partnership between the NHS, academics and business with patients and the public is crucial to ensure the benefits are far reaching for everyone living in the UK.
We look forward to working with UKRI, these new centres, our partners and patients and the public as we develop our approach for the trustworthy use of health data for research and innovation at scale across the UK.”
Diabetes patients set to benefit from heart disease data investment
7 July 2022
People living with diabetes could be set to benefit from a major research initiative to untangle the link between diabetes and heart disease – two of the most pressing global health crises. The...
Relationship between asthma and severe COVID-19: a national cohort study
1 July 2022
Previously, there has been conflicting evidence on how an asthma diagnosis affects the risk of severe COVID-19 cases. A new analysis of health records of 38 million people in England found that...
An Expanded Genome-Wide Association Study of Fructosamine Levels Identifies RCN3 as a Replicating Locus and Implicates FCGRT as the Effector Transcript
21 June 2022
The current standard measure of glucose control is not useful for measuring short-term changes and can struggle to work in people with some blood conditions. Researchers supported by HDR UK used a...